E Fund Management Co., Ltd. Alkermes Plc. Transaction History
E Fund Management Co., Ltd.
- $1.97 Billion
- Q4 2024
A detailed history of E Fund Management Co., Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 14,895 shares of ALKS stock, worth $403,803. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,895
Previous 16,413
9.25%
Holding current value
$403,803
Previous $459,000
6.75%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding ALKS
# of Institutions
385Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$789 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$501 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$332 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$239 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$205 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.45B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...